当前位置:首页 > 期刊 > 《中国当代医药》 > 2015年第18期 > 正文
编号:12598397
原发性肝癌TACE治疗后的影像学评价(1)
http://www.100md.com 2015年6月25日 中国当代医药2015年第18期
     [摘要] 原发性肝癌是严重威胁人类健康及寿命的恶性肿瘤之一,经动脉导管化疗栓塞术(TACE)是治疗原发性肝癌应用较为广泛的非外科手术治疗方法,准确地判断肝癌TACE治疗术后的疗效直接关系到临床治疗方案的选择及预后。目前,临床上对肝癌TACE术后的影像学检查方法众多,本文主要针对超声、CT、MR、DSA及PET/CT等影像学检查方法在肝癌TACE治疗后疗效评估中应用的现状进行综述。

    [关键词] 原发性肝癌;经动脉导管化疗栓塞术;超声;CT;MRI;DSA;PET/CT

    [中图分类号] R735.7 [文献标识码] A [文章编号] 1674-4721(2015)06(c)-0017-04

    [Abstract] Primary hepatic carcinoma is one of the serious diseases that threaten human beings′health and life.Transarterial chemoembolization(TACE) has become a nonsurgical treatment now widely and commonly used in the clinical practice.Correctly assessing the therapeutic efficacy of TACE for primary hepatic carcinoma is clinically very important as the judgment is directly related to the reasonable selection of therapeutic scheme as well as to the precise expectation of the prognosis.Nowadays ......
1 2 3 4下一页

您现在查看是摘要页,全文长 4088 字符